25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood.
Lohani
Sudhir
S
O'Driscoll
B Ronan
BR
Woodcock
Ashley A
AA
D000293:Adolescent; D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy*; D002330:Carmustine / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D012307:Risk Factors
D018906:Antineoplastic Agents, Alkylating; D002330:Carmustine